WallStreetZenWallStreetZen

NASDAQ: INM
Inmed Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Inmed Pharmaceuticals earnings were -$7.9M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest INM earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$2.6M, up 53.5% from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, INM reported annual earnings of -$7.7M, with -3.4% growth.

INM earnings history

Current Revenue
$4.8M
Current Earnings
-$7.9M
Current Profit Margin
-163.8%

INM Return on Equity

Current Company
-90.7%
Current Industry
59.7%
Current Market
41.7%
INM's Return on Equity (-90.7%)... subscribe to Premium to read more.
High Return on Equity Performance

INM Return on Assets

Current Company
-71.7%
Current Industry
18.9%
INM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when INM announces earnings.

INM Return on Capital Employed

Current Company
-112.57%
Current Industry
35.6%
INM's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

INM vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
INM-$6.98M-$7.91MN/A-$13.75
LIXT-$3.98M-$4.00MN/A-$1.73
TTNP-$5.86M-$5.89MN/A-$6.97
GLMD-$6.70M-$6.32MN/A-$18.99
GNPX-$22.70M-$22.71MN/A-$11.68
View Top Biotech Stocks

Inmed Pharmaceuticals Earnings Reports & History FAQ

What were Inmed Pharmaceuticals's earnings last quarter?

On INM's earnings call on Invalid Date, Inmed Pharmaceuticals (NASDAQ: INM) reported Q4 2024 earnings per share (EPS) of -$3.64, up 1.89% year over year. Total INM earnings for the quarter were -$2.58 million. In the same quarter last year, Inmed Pharmaceuticals's earnings per share (EPS) was -$3.71.

If you're new to stock investing, here's how to buy Inmed Pharmaceuticals stock.

Is Inmed Pharmaceuticals profitable or losing money?

As of the last Inmed Pharmaceuticals earnings report, Inmed Pharmaceuticals is currently losing money. Inmed Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$7.91 million, a 24.59% increase year over year.

What was INM's earnings growth in the past year?

As of Inmed Pharmaceuticals's earnings date in Invalid Date, Inmed Pharmaceuticals's earnings has grown year over year. INM earnings in the past year totalled -$7.91 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.